Reply With Quote
Your daily reminder that you're a ty scientist.
Your daily reminder that you're a ty scientist.
yeah that lady and her gripes were gone in 2010. Science moves forward, she was wrong. She wanted to be a gadfly, but gadflies who look for attention instead of doing things correctly often get crushed.I would like to remind you that I dont know science.
wtf are vaccine particles?
You should be able to answer this if you understand your post.
It's a particle from the vaccine. Are you crying because you don't know what's in the vaccine, ty scientist?
Mother er Biden lost another 3,000+ American souls to (19) this week, that's 7k over the last fortnight.
What particle from the vaccine you fool?
You were the one that wrote down all the things that are in the vaccine?
I'm so sorry this is happening to you.
Chumpettes not been crying about the numbers now that they have their installed president.
Am surprised that derptacular did not bring up spleen. But he knows nothing about biology.
Abstract
Virus-like particles (VLPs) are multiprotein structures that mimic the organization and conformation of authentic native viruses but lack the viral genome, potentially yielding safer and cheaper vaccine candidates. A handful of prophylactic VLP-based vaccines is currently commercialized worldwide: GlaxoSmithKline's Engerix (hepa is B virus) and Cervarix (human papillomavirus), and Merck and Co., Inc.'s Recombivax HB (hepa is B virus) and Gardasil (human papillomavirus) are some examples. Other VLP-based vaccine candidates are in clinical trials or undergoing preclinical evaluation, such as, influenza virus, parvovirus, Norwalk and various chimeric VLPs. Many others are still restricted to small-scale fundamental research, despite their success in preclinical tests. This article focuses on the essential role of VLP technology in new-generation vaccines against prevalent and emergent diseases. The implications of large-scale VLP production are discussed in the context of process control, monitorization and optimization. The main up- and down-stream technical challenges are identified and discussed accordingly. Successful VLP-based vaccine blockbusters are briefly presented concomitantly with the latest results from clinical trials and the recent developments in chimeric VLP-based technology for either therapeutic or prophylactic vaccination.
You'd think a biochemist would know these things.
DerpMC trying to help his buddy with furious copypasta.
He has me on ignore, Blake Zero.
You're a low-level poster.
For the most part. That doesn't stop you from humping his leg though.
Find just one post in the last three months that DMC has directly responded to me in ST Political.
You think you're worth responding to?
Yes or no.
Gambit. You just got your kicked in.
You're a low-level poster.
Declares victory.
Are you worth responding to, derp?
Yes or no.
You're the one so sure of yourself but can't produce one time in recent memory that DMC responded to me in ST Political.
Declares victory.
Are you worth responding to, derp?
Yes or no.
Just admit you were being a low-level poster instead of crying about it.
I never claimed he responded to your dumbass posts, derp.
Your posts are stupid and repe ive.
Did you not understand the words again, derp?
Big words show Derptacular's low iq bona fides.I never claimed he responded to your dumbass posts, derp.
Your posts are stupid and repe ive.
Did you not understand the words again, derp?
I rarely read your sh**, effeminate man. So unless your giving chump the standard sucking off, I don't know why you're spinning your wheels.
There are currently 1 users browsing this thread. (0 members and 1 guests)
Posting Permissions
